Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Significant worldwide disparities seen in availability and timeliness of new cancer drugs

2.

Canadian Group Calls for Earlier Colorectal Cancer Screening

3.

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

4.

Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study

5.

Pressing the Sleep button could have a positive impact on cognition.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot